Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(20%)
Results Posted
33%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
2
40%
Ph phase_1
1
20%
Ph not_applicable
2
40%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 22 (40.0%)
N/A2 (40.0%)

Trials by Status

recruiting120%
terminated120%
completed360%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_2

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

NCT02605421
completednot_applicable

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

NCT01505569
completednot_applicable

High Dose Chemotherapy and Autologous Transplant for Neuroblastoma

NCT01526603
terminatedphase_2

Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma

NCT01886105
completedphase_1

CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction

NCT00893360

Clinical Trials (5)

Showing 5 of 5 trials
NCT02605421Phase 2

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

Recruiting
NCT01505569Not Applicable

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Completed
NCT01526603Not Applicable

High Dose Chemotherapy and Autologous Transplant for Neuroblastoma

Completed
NCT01886105Phase 2

Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma

Terminated
NCT00893360Phase 1

CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction

Completed

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5